Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 8, 2015 - Issue 1
Submit an article Journal homepage
668
Views
99
CrossRef citations to date
0
Altmetric
Review

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

Brian GodmanDepartment of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden;Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK;Liverpool Health Economics Centre, University of Liverpool Management School, Liverpool, UKCorrespondence[email protected]
,
Rickard E MalmströmDepartment of Medicine, Clinical Pharmacology Unit, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden
,
Eduardo DiogeneVall d’Hebron University Hospital, Fundació Institut Català de Farmacologia, Pg Vall d’Hebron 119-129, 08035 Barcelona, Spain
,
Andy GrayDivision of Pharmacology, Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, PBag 7 Congella 4013, South Africa
,
Sisira JayathissaDepartment of Medicine, Hutt Valley DHB, Lower Hutt, Wellington, New Zealand
,
Angela TimoneyStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK;NHS Lothian Director of Pharmacy, Edinburgh, UK
,
Francisco AcurcioMedical College, Federal University of Minas Gerais (UFMG), Av. Alfredo Balena, 190, 7th floor, CEP 30130-100, Belo Horizonte, MG, Brazil;Pharmacy College, Federal University of Minas Gerais (UFMG), Av. Antônio Carlos, 6627, sl 1048, CEP 31270-901, Belo Horizonte, MG, Brazil
,
Ali AlkanDepartment of Rational Drug Use, Turkish Medicines and Medical Devices Agency, Ministry of Health of Turkey, Ankara, Turkey
,
Anna BrzezinskaAgency for Health Technology Assessment, Warsaw, Poland
,
Anna BucsicsUniversity of Vienna, Vienna, Austria
,
Stephen M CampbellCentre for Primary Care, Institute of Population Health, University of Manchester, Manchester M13 9PL, UK;NIHR Greater Manchester Primary Care Patient Safety Translational Research Centre, Institute of Population Health, University of Manchester, Manchester M13 9PL, UK
,
Jadwiga CzeczotDepartment of Rational Drug Use, Turkish Medicines and Medical Devices Agency, Ministry of Health of Turkey, Ankara, Turkey
,
Winnie de BruynDepartment of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
,
Irene ErikssonPublic Healthcare Services Committee Administration, Stockholm County Council, Stockholm, Sweden
,
Faridah Aryani Md YusofPharmaceutical Services Division, Ministry of Health,Malaysia
,
Alexander E FinlaysonNuffield Department of Primary Care Health Sciences, Green-Templeton College, Oxford University and Academic Clinical Fellow, University of Oxford, 48 Woodstock Road, Oxford OX2 6HG, UK
,
Jurij FürstHealth Insurance Institute, Ljubljana, Slovenia
,
Kristina GaruolieneFaculty of Medicine (Department of Pathology, Forensic Medicine and Pharmacology), Vilnius University, Vilnius, Lithuania;Medicines Reimbursement Department, National Health Insurance Fund, 1 Europos, Vilnius, Lithuania
,
Augusto Guerra JúniorPharmacy College, Federal University of Minas Gerais (UFMG), Av. Antônio Carlos, 6627, sl 1048, CEP 31270-901, Belo Horizonte, MG, Brazil
,
Jolanta GulbinovičFaculty of Medicine (Department of Pathology, Forensic Medicine and Pharmacology), Vilnius University, Vilnius, Lithuania;State Medicines Control Agency, Vilnius, Lithuania
,
Saira JanRutgers State University of New Jersey, Piscataway, NJ, USA;Horizon Blue Cross Blue Shield of New Jersey, Newark, NJ, USA
,
Roberta JoppiPharmaceutical Drug Department, Azienda Sanitaria Locale of Verona, Verona, Italy
,
Marija KalabaRepublic Institute for Health Insurance, Belgrade, Serbia
,
Einar MagnissonDepartment of Health Services, Ministry of Health, Reykjavík, Iceland
,
Laura McCullaghNational Centre for Pharmacoeconomics, St James's Hospital, James's Street, Dublin, Ireland
,
Kaisa MiikkulainenDepartment of Learning, Informatics, Management and Ethics, Medical Management Centre, Karolinska Institutet, Stockholm, Sweden
,
Gabriela Ofierska-SujkowskaAgency for Health Technology Assessment, Warsaw, Poland
,
Hanne Bak PedersenHealth Technologies and Pharmaceuticals, Division of Health Systems and Public Health, WHO Regional Office for Europe, Copenhagen, Denmark
,
Gisbert SelkeWissenschaftliches Institut der AOK (WIdO), Berlin, Germany
,
Catherine SermetIRDES, 10, rue Vauvenargues, 75018 Paris, France
,
Susan SpillaneDepartment of Pharmacology and Therapeutics, Trinity College Dublin, Dublin, Ireland
,
Azuwana SupianPharmaceutical Services Division, Ministry of Health,Malaysia
,
Ilse TruterDepartment of Pharmacy, Drug Utilization Research Unit (DURU), Nelson Mandela Metropolitan University (NMMU), Port Elizabeth, 6031, South Africa
,
Vera Vlahović-PalčevskiUnit for Clinical Pharmacology, University Hospital Rijeka, Krešimirova 42, 51000 Rijeka, Croatia
,
Low Ee VienPharmaceutical Services Division, Ministry of Health,Malaysia
,
Elif H VuralDepartment of Economical Evaluations, Turkish Medicines and Medical Devices Agency, Ministry of Health of Turkey, Ankara, Turkey
,
Janet WaleVictoria, Melbourne, Australia
,
Magdałene WładysiukHTA Consulting, Cracow, Poland
,
Wenjie ZengSchool of Management, Chongqing Jiaotong University, No. 66 Xuefu Road, Nan’an District, Chongqing 400074, China
&
Lars L GustafssonDepartment of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
 show all
Pages 77-94 | Published online: 09 Dec 2014

Citations (99)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (26)

Olga Pitsillidou, Panagiotis Petrou & M. J. Postma. (2023) Implementing a Managed Entry Agreement Framework in Cyprus. Expert Review of Pharmacoeconomics & Outcomes Research 23:8, pages 857-865.
Read now
Jaykaran Charan, Rimple Jeet Kaur, Pankaj Bhardwaj, Mainul Haque, Praveen Sharma, Sanjeev Misra & Brian Godman. (2021) Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications. Expert Review of Clinical Pharmacology 14:1, pages 95-103.
Read now
Brian Godman, Debashis Basu, Yogan Pillay, Paulo H. R. F. Almeida, Julius C. Mwita, Godfrey Mutashambara Rwegerera, Bene D Anand Paramadhas, Celda Tiroyakgosi, Okwen Patrick, Loveline Lum Niba, Israel Sefah, Margaret Oluka, Anastasia N Guantai, Dan Kibuule, Francis Kalemeera, Mwangana Mubita, Joseph Fadare, Olayinka O. Ogunleye, Enos M Rampamba, Jeffrey Wing, Debjani Mueller, Abubakr Alfadl, Adefolarin A Amu, Zinhle Matsebula, Aubrey C. Kalungia, Trust Zaranyika, Nyasha Masuka, Janney Wale, Ruaraidh Hill, Amanj Kurdi, Angela Timoney, Stephen Campbell & Johanna C Meyer. (2020) Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future. Hospital Practice 48:2, pages 51-67.
Read now
Brian Godman, Mainul Haque, Judy McKimm, Muhamad Abu Bakar, Jacqueline Sneddon, Janney Wale, Stephen Campbell, Antony P. Martin, Iris Hoxha, Vafa Abilova, Bene D. Anand Paramadhas, Pinkie Mpinda-Joseph, Matshediso Matome, Livia Lovato Pires de Lemos, Israel Sefah, Amanj Kurdi, Sylvia Opanga, Arianit Jakupi, Zikria Saleem, Mohamed Azmi Hassali, Dan Kibuule, Joseph Fadare, Tomasz Bochenek, Celia Rothe, Jurij Furst, Vanda Markovic-Pekovic, Ljubica Bojanić, Natalie Schellack, Johanna C. Meyer, Zinhle Matsebula, Thuy Nguyen Thi Phuong, Binh Nguyen Thanh, Saira Jan, Aubrey Kalungia, Sekesai Mtapuri-Zinyowera, Massimo Sartelli & Ruaraidh Hill. (2020) Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future. Current Medical Research and Opinion 36:2, pages 301-327.
Read now
Brian Godman, Holly McCabe, Trudy D Leong, Debjani Mueller, Antony P. Martin, Iris Hoxha, Julius C. Mwita, Godfrey Mutashambara Rwegerera, Amos Massele, Juliana de Oliveira Costa, Renata Cristina Rezende Macedo do Nascimento, Livia Lovato Pires de Lemos, Konstantin Tachkov, Petya Milushewa, Okwen Patrick, Loveline Lum Niba, Ott Laius, Israel Sefah, Suhaj Abdulsalim, Fatemeh Soleymani, Anastasia N Guantai, Loice Achieng, Margaret Oluka, Arianit Jakupi, Konstantīns Logviss, Mohamed Azmi Hassali, Dan Kibuule, Francis Kalemeera, Mwangana Mubita, Joseph Fadare, Olayinka O. Ogunleye, Zikria Saleem, Shazhad Hussain, Tomasz Bochenek, Ileana Mardare, Alian A. Alrasheedy, Jurij Furst, Dominik Tomek, Vanda Markovic-Pekovic, Enos M. Rampamba, Abubakr Alfadl, Adefolarin A Amu, Zinhle Matsebula, Thuy Nguyen Thi Phuong, Binh Nguyen Thanh, Aubrey Chichonyi Kalungia, Trust Zaranyika, Nyasha Masuka, Ioana D. Olaru, Janney Wale, Ruaraidh Hill, Amanj Kurdi, Angela Timoney, Stephen Campbell & Johanna C. Meyer. (2020) Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries. Expert Review of Pharmacoeconomics & Outcomes Research 20:1, pages 1-26.
Read now
Brian Godman, Christoffel Grobler, Marianne Van-De-Lisle, Janney Wale, Wallace Breno Barbosa, Amos Massele, Philip Opondo, Guenka Petrova, Konstantin Tachkov, Israel Sefah, Suhaj Abdulsalim, Alian A. Alrasheedy, Mazhuvancherry Kesavan Unnikrishnan, Kristina Garuoliene, Kayode Bamitale, Dan Kibuule, Francis Kalemeera, Joseph Fadare, Tanveer Ahmed Khan, Shahzad Hussain, Tomasz Bochenek, Aubrey Chichonyi Kalungia, James Mwanza, Antony P Martin, Ruaraidh Hill & Corrado Barbui. (2019) Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries. Expert Opinion on Pharmacotherapy 20:18, pages 2237-2255.
Read now
Esteban Ortiz-Prado, Gabriel Cevallos-Sierra, Enrique Teran, Eduardo Vasconez, Daniel Borrero-Maldonado, Jorge Ponce Zea, Katherine Simbaña-Rivera & Lenin Gómez-Barreno. (2019) Drug prices and trends before and after requesting compulsory licenses: the Ecuadorian experience. Expert Opinion on Therapeutic Patents 29:8, pages 653-662.
Read now
Patricia Vella Bonanno, Anna Bucsics, Steven Simoens, Antony P Martin, Wija Oortwijn, Jolanta Gulbinovič, Celia Rothe, Angela Timoney, Alessandra Ferrario, Mohamed Gad, Ahmed Salem, Iris Hoxha, Robert Sauermann, Maria Kamusheva, Maria Dimitrova, Guenka Petrova, Ott Laius, Gisbert Selke, Vasilios Kourafalos, John Yfantopoulos, Einar Magnusson, Roberta Joppi, Arianit Jakupi, Tomasz Bochenek, Magdalene Wladysiuk, Claudia Furtado, Vanda Marković-Peković, Ileana Mardare, Dmitry Meshkov, Jurij Fürst, Dominik Tomek, Merce Obach Cortadellas, Corrine Zara, Alan Haycox, Stephen Campbell & Brian Godman. (2019) Proposal for a regulation on health technology assessment in Europe – opinions of policy makers, payers and academics from the field of HTA. Expert Review of Pharmacoeconomics & Outcomes Research 19:3, pages 251-261.
Read now
Jörg Mahlich, Jörn Sindern & Moritz Suppliet. (2019) Cross-national drug price comparisons with economic weights in external reference pricing in Germany. Expert Review of Pharmacoeconomics & Outcomes Research 19:1, pages 37-43.
Read now
Panagiotis Petrou. (2018) The quest for the in medio stat virtus price in the oncology sector. Journal of Medical Economics 21:10, pages 1023-1025.
Read now
André Soares Santos, Augusto Afonso Guerra-Junior, Brian Godman, Alec Morton & Cristina Mariano Ruas. (2018) Cost-effectiveness thresholds: methods for setting and examples from around the world. Expert Review of Pharmacoeconomics & Outcomes Research 18:3, pages 277-288.
Read now
Peter Hertzman, Paul Miller & Keith Tolley. (2018) An assessment of innovative pricing schemes for the communication of value: is price discrimination and two-part pricing a way forward?. Expert Review of Pharmacoeconomics & Outcomes Research 18:1, pages 5-12.
Read now
Moliehi Matlala, Andries GS Gous, Brian Godman & Johanna C Meyer. (2017) Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications. Expert Review of Clinical Pharmacology 10:11, pages 1273-1280.
Read now
Peslie G Ngambi, Aubrey C Kalungia, Michael R Law, Francis Kalemeera, IIse Truter, Brian Godman & Derick Munkombwe. (2017) Evidence on the cost-effectiveness of lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV: implications for resource-limited countries in sub-Saharan Africa. Expert Review of Pharmacoeconomics & Outcomes Research 17:5, pages 459-467.
Read now
Daniel Kwame Afriyie, Seth Kwabena Amponsah, Justice Dogbey, Kwabena Agyekum, Samuel Kesse, Ilse Truter, Johanna C. Meyer & Brian Godman. (2017) A pilot study evaluating the prescribing of ceftriaxone in hospitals in Ghana: findings and implications. Hospital Practice 45:4, pages 143-149.
Read now
Tomasz Bochenek, Ewa Kocot, Marcin Rodzinka, Brian Godman, Katarzyna Maciejewska, Susan Kamal & Andrzej Pilc. (2017) The transparency of published health technology assessment-based recommendations on pharmaceutical reimbursement in Poland. Expert Review of Pharmacoeconomics & Outcomes Research 17:4, pages 385-400.
Read now
E Gray, A O’Leary, C Bergin, M Cannon, G Courtney, O Crosbie, CF De Gascun, L J Fanning, E Feeney, DD Houlihan, B Kelleher, J S Lambert, J Lee, PWG Mallon, S McConkey, A McCormick, S McKiernan, C McNally, F Murray, G Sheehan, S Stewart, C Walsh & S Norris. (2017) Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access program. Expert Review of Gastroenterology & Hepatology 11:6, pages 593-601.
Read now
Raphaela Marie Louisa Dierks, Olivier Bruyère & Jean-Yves Reginster. (2017) Micro factors bringing the pharmaceutical industry to a seismic shaking a qualitative research. Expert Review of Pharmacoeconomics & Outcomes Research 17:3, pages 267-274.
Read now
Gustavo Laine Araujo De Oliveira, Augusto Afonso Guerra Júnior, Brian Godman & Francisco de Assis Acurcio. (2017) Cost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications. Expert Review of Pharmacoeconomics & Outcomes Research 17:2, pages 109-119.
Read now
Sabine Vogler, Nina Zimmermann & Zaheer-Ud-Din Babar. (2017) Price comparison of high-cost originator medicines in European countries. Expert Review of Pharmacoeconomics & Outcomes Research 17:2, pages 221-230.
Read now
Brian Godman, Tanja Novakovic, Danka Tesic, Wija Oortwijn, Antony Paul Martin, Mark Parker & Alan Haycox. (2016) Addressing challenges for sustainable healthcare in Central and Eastern Europe. Expert Review of Pharmacoeconomics & Outcomes Research 16:6, pages 685-687.
Read now
Adriana Rodrigues da Mata, Juliana Álvares, Leonardo M Diniz, Michael Ruberson Ribeiro da Silva, Bárbara Rodrigues Alvernaz dos Santos, Augusto Afonso Guerra Júnior, Mariangela Leal Cherchiglia, Eli Iola Gurgel Andrade, Brian Godman & Francisco de Assis Acurcio. (2016) Quality of life of patients with Diabetes Mellitus Types 1 and 2 from a referal health centre in Minas Gerais, Brazil. Expert Review of Clinical Pharmacology 9:5, pages 739-746.
Read now
Daniel Resende Faleiros, Juliana Álvares, Alessandra Maciel Almeida, Vânia Eloisa de Araújo, Eli Iola Gurgel Andrade, Brian B. Godman, Francisco A. Acurcio & Augusto A. Guerra Júnior. (2016) Budget impact analysis of medicines: updated systematic review and implications. Expert Review of Pharmacoeconomics & Outcomes Research 16:2, pages 257-266.
Read now
Govin Permanand & Hanne Bak Pedersen. (2015) Managing new premium-priced medicines in Europe. Journal of Pharmaceutical Policy and Practice 8:sup1.
Read now
Wojciech Matusewicz, Brian Godman, Hanne Bak Pedersen, Jurij Fürst, Jolanta Gulbinovič, Asbjørn Mack, Gisbert Selke, Angela Timoney, Ewa Warmińska & Rickard E Malmström. (2015) Improving the managed introduction of new medicines: sharing experiences to aid authorities across Europe. Expert Review of Pharmacoeconomics & Outcomes Research 15:5, pages 755-758.
Read now
Amos Massele, Brian Godman, Matthias Adorka, Joseph Fadare, Andy Gray, Martie Lubbe, Olayinka Ogunleye & Ilse Truter. (2015) Initiative to progress research on medicine utilization in Africa: formation of the Medicines Utilization Research in Africa group. Expert Review of Pharmacoeconomics & Outcomes Research 15:4, pages 607-610.
Read now

Articles from other publishers (73)

David Elvira, Ferran Torres, Roser Vives, Gemma Puig, Mercè Obach, Daniel Gay, Daniel Varón, Thais de Pando, Josep Tabernero & Caridad Pontes. (2023) Reporting reimbursement price decisions for onco-hematology drugs in Spain. Frontiers in Public Health 11.
Crossref
Olayinka Ogunleye, Brian Godman, Joseph Fadare, Steward Mudenda, Adekunle Adeoti, Adesola Yinka-Ogunleye, Sunday Ogundele, Modupe Oyawole, Marione Schönfeldt, Wafaa Rashed, Ahmad Galal, Nyasha Masuka, Trust Zaranyika, Aubrey Kalungia, Oliver Malande, Dan Kibuule, Amos Massele, Ibrahim Chikowe, Felix Khuluza, Tinotenda Taruvinga, Abubakr Alfadl, Elfatih Malik, Margaret Oluka, Sylvia Opanga, Daniel Ankrah, Israel Sefah, Daniel Afriyie, Eunice Tagoe, Adefolarin Amu, Mlungisi Msibi, Ayukafangha Etando, Mobolaji Alabi, Patrick Okwen, Loveline Niba, Julius Mwita, Godfrey Rwegerera, Joyce Kgatlwane, Ammar Jairoun, Chioma Ejekam, Rooyen Mavenyengwa, Irene Murimi-Worstell, Stephen Campbell & Johanna Meyer. (2022) Coronavirus Disease 2019 (COVID-19) Pandemic across Africa: Current Status of Vaccinations and Implications for the Future. Vaccines 10:9, pages 1553.
Crossref
Alice Pisana, Björn Wettermark, Amanj Kurdi, Biljana Tubic, Caridad Pontes, Corinne Zara, Eric Van Ganse, Guenka Petrova, Ileana Mardare, Jurij Fürst, Marta Roig-Izquierdo, Oyvind Melien, Patricia Vella Bonanno, Rita Banzi, Vanda Marković-Peković, Zornitsa Mitkova & Brian Godman. (2022) Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries. Frontiers in Pharmacology 13.
Crossref
Carlo Giacomo Leo, Maria Rosaria Tumolo, Saverio Sabina, Riccardo Colella, Virginia Recchia, Giuseppe Ponzini, Dimitrios Ioannis Fotiadis, Antonella Bodini & Pierpaolo Mincarone. (2022) Health Technology Assessment for In Silico Medicine: Social, Ethical and Legal Aspects. International Journal of Environmental Research and Public Health 19:3, pages 1510.
Crossref
Néboa Zozaya, Teresa Caballero, Teresa González-Quevedo, Pedro Gamboa Setien, M. Ángeles González, Ramón Jódar, José Luis Poveda-Andrés, Encarna Guillén-Navarro, Agustín Rivero Cuadrado & Álvaro Hidalgo-Vega. (2022) A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain. Global & Regional Health Technology Assessment 9, pages 14-21.
Crossref
David Elvira, Mercè Obach & Caridad Pontes. (2021) Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies. BMC Health Services Research 21:1.
Crossref
Wolfgang Greiner, Keyur Patel, Christina-Jane Crossman-Barnes, Troels Vingtoft Rye-Andersen, Christian Hvid & Tom Vandebrouck. (2021) High-Expenditure Disease in the EU-28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes?. PharmacoEconomics - Open 5:3, pages 385-396.
Crossref
Michael Kossmeier, Madeleine Themanns, Lena Hatapoglu, Bernhard Kogler, Simon Keuerleber, Jutta Lichtenecker, Robert Sauermann, Anna Bucsics, Michael Freissmuth & Eva Zebedin-Brandl. (2021) Assessing the Accuracy of Sales Forecasts Submitted by Pharmaceutical Companies Applying for Reimbursement in Austria. Frontiers in Pharmacology 12.
Crossref
Brian Godman, Joseph Fadare, Hye-Young Kwon, Carolina Zampirolli Dias, Amanj Kurdi, Isabella Piassi Dias Godói, Dan Kibuule, Iris Hoxha, Sylvia Opanga, Zikria Saleem, Tomasz Bochenek, Vanda Marković-Peković, Ileana Mardare, Aubrey C Kalungia, Stephen Campbell, Eleonora Allocati, Alice Pisana, Antony P Martin & Johanna C Meyer. (2021) Evidence-based public policy making for medicines across countries: findings and implications for the future. Journal of Comparative Effectiveness Research 10:12, pages 1019-1052.
Crossref
Fanny Monmousseau, Julien Ramillon, Sophie Dubnitskiy-Robin, Benjamin Faivre d’Arcier, Martine Le Verger, Tanguy Le Fol, Franck Bruyère, Emmanuel Rusch, Solène Brunet-Houdard & Benjamin Pradère. (2021) Relevance of Adopting a Hybrid Strategy Mixing Single-Use and Reusable Ureteroscopes for Stones Management: An Economic Study to Support the Best Strategy. Journal of Clinical Medicine 10:12, pages 2593.
Crossref
Stephanie Ferreira Botelho, Laís Lessa Neiva Pantuzza, Claudyane Pinheiro Marinho & Adriano Max Moreira Reis. (2021) Prognostic prediction models and clinical tools based on consensus to support patient prioritization for clinical pharmacy services in hospitals: A scoping review. Research in Social and Administrative Pharmacy 17:4, pages 653-663.
Crossref
Amanda Whittal, Elena Nicod, Mike Drummond & Karen Facey. (2021) Examining the impact of different country processes for appraising rare disease treatments: a case study analysis. International Journal of Technology Assessment in Health Care 37:1.
Crossref
Rama Mehra & Milind Kumar Sharma. (2021) Measures of Sustainability in Healthcare. Sustainability Analytics and Modeling 1, pages 100001.
Crossref
Patricia Vella Bonanno, Alec Morton & Brian Godman. 2021. Expert Judgement in Risk and Decision Analysis. Expert Judgement in Risk and Decision Analysis 419 439 .
Elena Nicod, Amanda Whittal, Michael Drummond & Karen Facey. (2020) Are supplemental appraisal/reimbursement processes needed for rare disease treatments? An international comparison of country approaches. Orphanet Journal of Rare Diseases 15:1.
Crossref
Love Linnér, Irene Eriksson, Marie Persson & Björn Wettermark. (2020) Forecasting drug utilization and expenditure: ten years of experience in Stockholm. BMC Health Services Research 20:1.
Crossref
Olga A. Belousova, Aard J. Groen & Aniek M. Ouendag. (2020) Opportunities and barriers for innovation and entrepreneurship in orphan drug development. Technological Forecasting and Social Change 161, pages 120333.
Crossref
Carolina Zampirolli Dias, Brian Godman, Ludmila Peres Gargano, Pâmela Santos Azevedo, Marina Morgado Garcia, Maurílio Souza Cazarim, Laís Lessa Neiva Pantuzza, Nelio Gomes Ribeiro-Junior, André Luiz Pereira, Marcus Carvalho Borin, Isabella de Figueiredo Zuppo, Roberto Iunes, Tomas Pippo, Renata Curi Hauegen, Carlos Vassalo, Tracey-Lea Laba, Steven Simoens, Sergio Márquez, Carolina Gomez, Luka Voncina, Gisbert W. Selke, Livio Garattini, Hye-Young Kwon, Jolanta Gulbinovic, Aneta Lipinska, Maciej Pomorski, Lindsay McClure, Jurij Fürst, Rosana Gambogi, Carla Hernandez Ortiz, Vânia Cristina Canuto Santos, Denizar Vianna Araújo, Vânia Eloisa Araujo, Francisco de Assis Acurcio, Juliana Alvares-Teodoro & Augusto Afonso Guerra-Junior. (2020) Integrative Review of Managed Entry Agreements: Chances and Limitations. PharmacoEconomics 38:11, pages 1165-1185.
Crossref
Olayinka O. Ogunleye, Debashis Basu, Debjani Mueller, Jacqueline Sneddon, R. Andrew Seaton, Adesola F. Yinka-Ogunleye, Joshua Wamboga, Nenad Miljković, Julius C. Mwita, Godfrey Mutashambara Rwegerera, Amos Massele, Okwen Patrick, Loveline Lum Niba, Melaine Nsaikila, Wafaa M. Rashed, Mohamed Ali Hussein, Rehab Hegazy, Adefolarin A. Amu, Baffour Boaten Boahen-Boaten, Zinhle Matsebula, Prudence Gwebu, Bongani Chirigo, Nongabisa Mkhabela, Tenelisiwe Dlamini, Siphiwe Sithole, Sandile Malaza, Sikhumbuzo Dlamini, Daniel Afriyie, George Awuku Asare, Seth Kwabena Amponsah, Israel Sefah, Margaret Oluka, Anastasia N. Guantai, Sylvia A. Opanga, Tebello Violet Sarele, Refeletse Keabetsoe Mafisa, Ibrahim Chikowe, Felix Khuluza, Dan Kibuule, Francis Kalemeera, Mwangana Mubita, Joseph Fadare, Laurien Sibomana, Gwendoline Malegwale Ramokgopa, Carmen Whyte, Tshegofatso Maimela, Johannes Hugo, Johanna C. Meyer, Natalie Schellack, Enos M. Rampamba, Adel Visser, Abubakr Alfadl, Elfatih M. Malik, Oliver Ombeva Malande, Aubrey C. Kalungia, Chiluba Mwila, Trust Zaranyika, Blessmore Vimbai Chaibva, Ioana D. Olaru, Nyasha Masuka, Janney Wale, Lenias Hwenda, Regina Kamoga, Ruaraidh Hill, Corrado Barbui, Tomasz Bochenek, Amanj Kurdi, Stephen Campbell, Antony P. Martin, Thuy Nguyen Thi Phuong, Binh Nguyen Thanh & Brian Godman. (2020) Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future. Frontiers in Pharmacology 11.
Crossref
Moliehi Matlala, Andries G. S. Gous, Johanna C. Meyer & Brian Godman. (2020) Formulary Management Activities and Practice Implications Among Public Sector Hospital Pharmaceutical and Therapeutics Committees in a South African Province. Frontiers in Pharmacology 11.
Crossref
Luciane Cruz Lopes, Brian Godman, Cristiane De Cássia Bergamaschi, Silvio Barberato-Filho & Marcus Tolentino Silva. (2020) Editorial: New Horizons in Health-Promoting Technologies: From Development to Rational Use. Frontiers in Pharmacology 11.
Crossref
Nenad Miljković, Eline van Overbeeke, Brian Godman, Milena Kovačević, Alison Anastasi, Tomasz Bochenek, Isabelle Huys & Branislava Miljković. (2020) Practical Implications From European Hospital Pharmacists on Prospective Risk Assessment for Medicine Shortages. Frontiers in Medicine 7.
Crossref
Isabela Vaz Leite Pinto, Marina Guimarães Lima, Laís Lessa Neiva Pantuzza, Maria das Graças Braga Ceccato, Micheline Rosa Silveira & Adriano Max Moreira Reis. (2020) Free access to medicines among older adults in primary care: a cross-sectional study. Sao Paulo Medical Journal 138:3, pages 235-243.
Crossref
Carina Schey, Maarten Jacobus Postma, Paul F. M. Krabbe, Olekdandr Topachevskyi, Andrew Volovyk & Mark Connolly. (2020) Assessing the Preferences for Criteria in Multi-Criteria Decision Analysis in Treatments for Rare Diseases. Frontiers in Public Health 8.
Crossref
Brian Godman, Debashis Basu, Yogan Pillay, Julius C. Mwita, Godfrey Mutashambara Rwegerera, Bene D. Anand Paramadhas, Celda Tiroyakgosi, Patrick Mbah Okwen, Loveline Lum Niba, Justice Nonvignon, Israel Sefah, Margaret Oluka, Anastasia N. Guantai, Dan Kibuule, Francis Kalemeera, Mwangana Mubita, Joseph Fadare, Olayinka O. Ogunleye, Larry A. Distiller, Enos M. Rampamba, Jeffrey Wing, Debjani Mueller, Abubakr Alfadl, Adefolarin A. Amu, Zinhle Matsebula, Aubrey Kalungia, Trust Zaranyika, Nyasha Masuka, Janney Wale, Ruaraidh Hill, Amanj Kurdi, Angela Timoney, Stephen Campbell & Johanna C. Meyer. (2020) Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future. Frontiers in Pharmacology 11.
Crossref
Mohamed Gad, Ahmed Salem, Wija Oortwijn, Ruaraidh Hill & Brian Godman. (2020) Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions. Frontiers in Pharmacology 11.
Crossref
Mackenzie Mills & Panos Kanavos. (2020) Do pharmaceutical budgets deliver financial sustainability in healthcare? Evidence from Europe. Health Policy 124:3, pages 239-251.
Crossref
Caridad Pontes, Corinne Zara, Josep Torrent-Farnell, Merce Obach, Cristina Nadal, Patricia Vella-Bonanno, Michael Ermisch, Steven Simoens, Renata Curi Hauegen, Jolanta Gulbinovic, Angela Timoney, Antony P. Martin, Tanja Mueller, Anna Nachtnebel, Stephen Campbell, Gisbert Selke, Tomasz Bochenek, Celia C. Rothe, Ileana Mardare, Marion Bennie, Jurij Fürst, Rickard E. Malmstrom & Brian Godman. (2019) Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab. Applied Health Economics and Health Policy 18:1, pages 5-16.
Crossref
André Soares Santos, Augusto Afonso Guerra-Junior, Kenya Valéria Micaela de Souza Noronha, Mônica Viegas Andrade & Cristina Mariano Ruas. (2019) The Price of Substitute Technologies. Value in Health Regional Issues 20, pages 154-158.
Crossref
Angela Acosta, Egdda Patricia Vanegas, Joan Rovira, Brian Godman & Tomasz Bochenek. (2019) Medicine Shortages: Gaps Between Countries and Global Perspectives. Frontiers in Pharmacology 10.
Crossref
Philippe Van Wilder, Magali Pirson & Alain Dupont. (2019) Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium. European Journal of Clinical Pharmacology 75:7, pages 895-900.
Crossref
Brian Godman, Amanj Kurdi, Holly McCabe, Chris F Johnson, Corrado Barbui, Sean MacBride-Stewart, Simon Hurding, Axel Leporowski, Marion Bennie & Alec Morton. (2019) Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence. Journal of Comparative Effectiveness Research 8:7, pages 535-547.
Crossref
Dominik J. Wettstein & Stefan Boes. (2018) Effectiveness of National Pricing Policies for Patent-Protected Pharmaceuticals in the OECD: A Systematic Literature Review. Applied Health Economics and Health Policy 17:2, pages 143-162.
Crossref
Irene Eriksson, Mia von Euler, Rickard E. Malmström, Brian Godman & Björn Wettermark. (2018) Did we see it Coming? An Evaluation of the Swedish Early Awareness and Alert System. Applied Health Economics and Health Policy 17:1, pages 93-101.
Crossref
Patrick M. Kivoto, Mercy Mulaku, Charles Ouma, Alessandra Ferrario, Amanj Kurdi, Brian Godman & Margaret Oluka. (2018) Clinical and Financial Implications of Medicine Consumption Patterns at a Leading Referral Hospital in Kenya to Guide Future Planning of Care. Frontiers in Pharmacology 9.
Crossref
Brian Godman, Anna Bucsics, Patricia Vella Bonanno, Wija Oortwijn, Celia C. Rothe, Alessandra Ferrario, Simone Bosselli, Andrew Hill, Antony P. Martin, Steven Simoens, Amanj Kurdi, Mohamed Gad, Jolanta Gulbinovič, Angela Timoney, Tomasz Bochenek, Ahmed Salem, Iris Hoxha, Robert Sauermann, Amos Massele, Augusto Alfonso GuerraJr.Jr., Guenka Petrova, Zornitsa Mitkova, Gnosia Achniotou, Ott Laius, Catherine Sermet, Gisbert Selke, Vasileios Kourafalos, John Yfantopoulos, Einar Magnusson, Roberta Joppi, Margaret Oluka, Hye-Young Kwon, Arianit Jakupi, Francis Kalemeera, Joseph O. Fadare, Oyvind Melien, Maciej Pomorski, Magdalene Wladysiuk, Vanda Marković-Peković, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Dominik Tomek, Corrine Zara, Eduardo Diogene, Johanna C. Meyer, Rickard Malmström, Björn Wettermark, Zinhle Matsebula, Stephen Campbell & Alan Haycox. (2018) Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets. Frontiers in Public Health 6.
Crossref
Jason C. Hsu, Sheng-Mao Chang & Christine Y. Lu. (2017) Geographic Variations and Time Trends in Cancer Treatments in Taiwan. BMC Public Health 18:1.
Crossref
Hye-Young Kwon, Hyungmin Kim & Brian Godman. (2018) Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications. Frontiers in Pharmacology 9.
Crossref
Denis Horgan. (2018) From here to 2025: Personalised medicine and healthcare for an immediate future. Journal of Cancer Policy 16, pages 6-21.
Crossref
Livia Lovato Pires de Lemos, Augusto Afonso Guerra Júnior, Marisa Santos, Carlos Magliano, Isabela Diniz, Kathiaja Souza, Ramon Gonçalves Pereira, Juliana Alvares, Brian Godman, Marion Bennie, Ivan Ricardo Zimmermann, Vânia Crisitna Canuto dos Santos, Clarice Alegre Pretramale & Francisco de Assis Acurcio. (2017) The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil. PharmacoEconomics 36:2, pages 161-173.
Crossref
Stephanie Ferreira Botelho, Maria Auxiliadora Parreiras Martins & Adriano Max Moreira Reis. (2018) Análise de medicamentos novos registrados no Brasil na perspectiva do Sistema Único de Saúde e da carga de doença. Ciência & Saúde Coletiva 23:1, pages 215-228.
Crossref
Chun K. K. Ma, Mark Danta, Richard Day & David D. F. Ma. (2018) Dealing with the spiralling price of medicines: issues and solutions. Internal Medicine Journal 48:1, pages 16-24.
Crossref
Pathiyil Ravi Shankar. 2018. Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries. Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries 229 245 .
Pricivel Carrera & S. Yousuf Zafar. 2018. The MASCC Textbook of Cancer Supportive Care and Survivorship. The MASCC Textbook of Cancer Supportive Care and Survivorship 127 143 .
Evelien Moorkens, Arnold G. Vulto, Isabelle Huys, Pieter Dylst, Brian Godman, Simon Keuerleber, Barbara Claus, Maria Dimitrova, Guenka Petrova, Ljiljana Sović-Brkičić, Juraj Slabý, Robin Šebesta, Ott Laius, Allan Karr, Morgane Beck, Jaana E. Martikainen, Gisbert W. Selke, Susan Spillane, Laura McCullagh, Gianluca Trifirò, Patricia Vella Bonanno, Asbjørn Mack, Antra Fogele, Anita Viksna, Magdalena Władysiuk, Helder Mota-Filipe, Dmitry Meshkov, Marija Kalaba, Simona Mencej Bedrač, Jurij Fürst, Corrine Zara, Peter Skiöld, Einar Magnússon & Steven Simoens. (2017) Policies for biosimilar uptake in Europe: An overview. PLOS ONE 12:12, pages e0190147.
Crossref
N. Maniadakis, G. Kourlaba, J. Shen & A. Holtorf. (2017) Comprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status. BMC Health Services Research 17:1.
Crossref
Alessandra Ferrario, Diāna Arāja, Tomasz Bochenek, Tarik Čatić, Dávid Dankó, Maria Dimitrova, Jurij Fürst, Ieva Greičiūtė-Kuprijanov, Iris Hoxha, Arianit Jakupi, Erki Laidmäe, Olga Löblová, Ileana Mardare, Vanda Markovic-Pekovic, Dmitry Meshkov, Tanja Novakovic, Guenka Petrova, Maciej Pomorski, Dominik Tomek, Luka Voncina, Alan Haycox, Panos Kanavos, Patricia Vella Bonanno & Brian Godman. (2017) The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications. PharmacoEconomics 35:12, pages 1271-1285.
Crossref
Laura McCullagh, Susanne Schmitz, Michael Barry & Cathal Walsh. (2017) Examining the Feasibility and Utility of Estimating Partial Expected Value of Perfect Information (via a Nonparametric Approach) as Part of the Reimbursement Decision-Making Process in Ireland: Application to Drugs for Cancer. PharmacoEconomics 35:11, pages 1177-1185.
Crossref
Irene Eriksson, Björn Wettermark, Marie Persson, Morgan Edström, Brian Godman, Anna Lindhé, Rickard E. Malmström, Helena Ramström, Mia von Euler & Anna Bergkvist Christensen. (2017) The Early Awareness and Alert System in Sweden: History and Current Status. Frontiers in Pharmacology 8.
Crossref
Andrej Janzic & Mitja Kos. (2017) Influence of novel oral anticoagulants on anticoagulation care management. Acta Pharmaceutica 67:3, pages 397-406.
Crossref
Rachel Magarinos-Torres, Larry David Lynd, Tatiana Chama Borges Luz, Paulo Eduardo Potyguara Coutinho Marques & Claudia Garcia Serpa Osorio-de-Castro. (2017) Essential Medicines List Implementation Dynamics: A Case Study Using Brazilian Federal Medicines Expenditures. Basic & Clinical Pharmacology & Toxicology 121:3, pages 181-188.
Crossref
Patricia Vella Bonanno, Michael Ermisch, Brian Godman, Antony P. Martin, Jesper Van Den Bergh, Liudmila Bezmelnitsyna, Anna Bucsics, Francis Arickx, Alexander Bybau, Tomasz Bochenek, Marc van de Casteele, Eduardo Diogene, Irene Eriksson, Jurij Fürst, Mohamed Gad, Ieva Greičiūtė-Kuprijanov, Martin van der Graaff, Jolanta Gulbinovic, Jan Jones, Roberta Joppi, Marija Kalaba, Ott Laius, Irene Langner, Ileana Mardare, Vanda Markovic-Pekovic, Einar Magnusson, Oyvind Melien, Dmitry O. Meshkov, Guenka I. Petrova, Gisbert Selke, Catherine Sermet, Steven Simoens, Ad Schuurman, Ricardo Ramos, Jorge Rodrigues, Corinne Zara, Eva Zebedin-Brandl & Alan Haycox. (2017) Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation. Frontiers in Pharmacology 8.
Crossref
Hye-Young Kwon & Brian Godman. (2017) Drug Pricing in South Korea. Applied Health Economics and Health Policy 15:4, pages 447-453.
Crossref
Vikas Saini, Sandra Garcia-Armesto, David Klemperer, Valerie Paris, Adam G Elshaug, Shannon Brownlee, John P A Ioannidis & Elliott S Fisher. (2017) Drivers of poor medical care. The Lancet 390:10090, pages 178-190.
Crossref
Jaran Eriksen, Lars L Gustafsson, Kristina Ateva, Pia Bastholm-Rahmner, Marie-Louise Ovesjö, Malena Jirlow, Maria Juhasz-Haverinen, Gerd Lärfars, Rickard E Malmström, Björn Wettermark & Eva Andersén-Karlsson. (2017) High adherence to the ‘Wise List’ treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines. BMJ Open 7:4, pages e014345.
Crossref
Ildar Akhmetov & Rostyslav V. Bubnov. (2017) Innovative payer engagement strategies: will the convergence lead to better value creation in personalized medicine?. EPMA Journal 8:1, pages 5-15.
Crossref
Hong Cai, Guichen Li, Ping Zhang, Duo Xu & Li Chen. (2016) Effect of exercise on the quality of life in type 2 diabetes mellitus: a systematic review. Quality of Life Research 26:3, pages 515-530.
Crossref
Isabella P. Godói, André S. Santos, Edna A. Reis, Livia L. P. Lemos, Cristina M. R. Brandão, Juliana Alvares, Francisco A. Acurcio, Brian Godman & Augusto A. Guerra Júnior. (2017) Consumer Willingness to Pay for Dengue Vaccine (CYD-TDV, Dengvaxia®) in Brazil; Implications for Future Pricing Considerations. Frontiers in Pharmacology 8.
Crossref
Sebastian Schee genannt Halfmann, Nikolaos Evangelatos, Peter Schröder-Bäck & Angela Brand. (2017) European healthcare systems readiness to shift from ‘one-size fits all’ to personalized medicine. Personalized Medicine 14:1, pages 63-74.
Crossref
Zezheng Gao, Qingwei Li, Xuemin Wu, Xuemin Zhao, Linhua Zhao & Xiaolin Tong. (2017) New Insights into the Mechanisms of Chinese Herbal Products on Diabetes: A Focus on the “Bacteria-Mucosal Immunity-Inflammation-Diabetes” Axis. Journal of Immunology Research 2017, pages 1-13.
Crossref
Brian Godman, Eduardo Diogene, Jurij Fürst, Kristina Garuoliene, Augusto Guerra, Roberta Joppi, Rickard Malmström, Wija Oortwijn, Gisbert Selke, Angela Timoney & Björn Wettermark. (2018) PP022 New Models Are Needed To Optimize The Management Of New Medicines. International Journal of Technology Assessment in Health Care 33:S1, pages 79-80.
Crossref
Brian Godman, Joseph Fadare, Dan Kibuule, Lyna Irawati, Mwangana Mubita, Olayinka Ogunleye, Margaret Oluka, Bene D. Anand Paramadhas, Juliana de Oliveira Costa, Lívia Lovato Pires de Lemos, Augusto Afonso Guerra Júnior, Alian A. Alrasheedy, Mohamed Azmi Hassali, Fahad Saleem, Thu Huong & Ilse Truter. 2017. Drug Resistance in Bacteria, Fungi, Malaria, and Cancer. Drug Resistance in Bacteria, Fungi, Malaria, and Cancer 539 576 .
Anthony Barron & Tim Wilsdon. (2016) Challenging Perceptions About Oncology Product Pricing in Breast and Colorectal Cancer. Pharmaceutical Medicine 30:6, pages 321-326.
Crossref
C. Wild, N. Grössmann, P.V. Bonanno, A. Bucsics, J. Furst, K. Garuoliene, B. Godman, J. Gulbinovič, J. Jones, M.K. Pomorski & R. Emprechtinger. (2016) Utilisation of the ESMO-MCBS in practice of HTA. Annals of Oncology 27:11, pages 2134-2136.
Crossref
Michael Ermisch, Anna Bucsics, Patricia Vella Bonanno, Francis Arickx, Alexander Bybau, Tomasz Bochenek, Marc van de Casteele, Eduardo Diogene, Jurij Fürst, Kristina Garuolienė, Martin van der Graaff, Jolanta Gulbinovič, Alan Haycox, Jan Jones, Roberta Joppi, Ott Laius, Irene Langner, Antony P. Martin, Vanda Markovic-Pekovic, Laura McCullagh, Einar Magnusson, Ellen Nilsen, Gisbert Selke, Catherine Sermet, Steven Simoens, Robert Sauermann, Ad Schuurman, Ricardo Ramos, Vera Vlahovic-Palcevski, Corinne Zara & Brian Godman. (2016) Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways. Frontiers in Pharmacology 7.
Crossref
Christen Rachul, Maeghan Toews & Timothy Caulfield. (2016) Controversies with Kalydeco: Newspaper coverage in Canada and the United States of the cystic fibrosis “wonder drug”. Journal of Cystic Fibrosis 15:5, pages 624-629.
Crossref
Winnie de Bruijn, Cristina Ibáñez, Pia Frisk, Hanne Bak Pedersen, Ali Alkan, Patricia Vella Bonanno, Ljiljana S. Brkičić, Anna Bucsics, Guillaume Dedet, Jaran Eriksen, Joseph O. Fadare, Jurij Fürst, Gisselle Gallego, Isabella P. Godói, Augusto A. Guerra Júnior, Hakkı Gürsöz, Saira Jan, Jan Jones, Roberta Joppi, Saim Kerman, Ott Laius, Newman Madzikwa, Einar Magnússon, Mojca Maticic, Vanda Markovic-Pekovic, Amos Massele, Olayinka Ogunleye, Aisling O'Leary, Jutta Piessnegger, Catherine Sermet, Steven Simoens, Celda Tiroyakgosi, Ilse Truter, Magnus Thyberg, Kristina Tomekova, Magdalena Wladysiuk, Sotiris Vandoros, Elif H. Vural, Corinne Zara & Brian Godman. (2016) Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future. Frontiers in Pharmacology 7.
Crossref
Jason C Hsu, Luis A Gonzalez-Gonzalez, Vicky H Lu & Christine Y Lu. (2016) Longitudinal trends in use of targeted therapies for treatment of malignant neoplasms of the eye: a population-based study in Taiwan. BMJ Open 6:5, pages e010706.
Crossref
Mark P. Murphy & Emma Caraher. (2016) Current and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its Symptoms. Drugs in R&D 16:1, pages 1-17.
Crossref
Elisabetta Poluzzi, Giacomo Veronese, Carlo Piccinni, Emanuel Raschi, Ariola Koci, Paola Pagano, Brian Godman, Giulio Marchesini, Giuseppe Boriani & Fabrizio De Ponti. (2016) Switching among Equivalents in Chronic Cardiovascular Therapies: ‘Real World’ Data from Italy. Basic & Clinical Pharmacology & Toxicology 118:1, pages 63-69.
Crossref
Suzanne S. Dunne & Colum P. Dunne. (2015) What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Medicine 13:1.
Crossref
Bonny Parkinson, Catherine Sermet, Fiona Clement, Steffan Crausaz, Brian Godman, Sarah Garner, Moni Choudhury, Sallie-Anne Pearson, Rosalie Viney, Ruth Lopert & Adam G. Elshaug. (2015) Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. PharmacoEconomics 33:9, pages 905-924.
Crossref
Isabelle Budin-Ljøsne & Jennifer R. Harris. (2015) Ask Not What Personalized Medicine Can Do for You - Ask What You Can Do for Personalized Medicine. Public Health Genomics 18:3, pages 131-138.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.